V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006961 | 10004806 | 1.82 | 108 | Adjuvant (A) | null | 2013-12-23 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | Y | 10484543 | CISPLATIN + RT |
| 10006962 | 10004807 | 1.6 | 81.7 | Palliative (P) | 2019-06-17 | 2019-06-17 | CISPLATIN + FLUOROURACIL | 02 | N | 10484570 | FEC + DOCETAXEL + TRASTUZUMAB |
| 10006963 | 10004808 | 1.74 | 67.35 | Neo-adjuvant (N) | 2015-06-15 | 2015-07-02 | NIVOLUMAB | N | N | 10484584 | ENZALUTAMIDE |
| 10006964 | 10004809 | 1.68 | 79.3 | Palliative (P) | 2016-01-14 | 2016-01-14 | PCV | 02 | N | 10484711 | ENZALUTAMIDE |
| 10006965 | 10004809 | 1.76 | 79.2 | Palliative (P) | 2018-01-01 | 2018-01-01 | BUSULFAN | 02 | N | 10484711 | ECX |
| 10006966 | 10004810 | 1.87 | 86.9 | Palliative (P) | 2017-06-21 | 2017-07-05 | Mitomycin Intravesical | 02 | N | 10484808 | CODOX M |
| 10006967 | 10004811 | 1.79 | 68.2 | Curative (C) | 2018-11-05 | 2018-11-19 | Enzalutamide | N | N | 10484886 | VINBLASTINE |
| 10006968 | 10004812 | 1.67 | 92.5 | Disease modification (D) | 2016-05-07 | 2016-05-28 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 10484954 | TRIFLURIDINE + TIPIRACIL |
| 10006969 | 10004813 | 1.79 | 95.1 | Palliative (P) | 2017-03-13 | 2017-04-05 | OXALIPLATIN | N | N | 10484984 | NILOTINIB |
| 10006970 | 10007429 | 1.77 | 67.8 | Adjuvant (A) | 2017-08-27 | 2017-08-27 | Bevacizumab + CAPECITABINE + OXALIPLATIN | 02 | N | 10484984 | CISPLATIN + RT |
| 10006971 | 10007429 | 1.62 | 79.4 | Palliative (P) | 2016-08-04 | 2016-08-11 | FCR Oral - Cycle 1 | 2 | N | 10484984 | CRIZOTINIB |
| 10006972 | 10004817 | 1.58 | null | Adjuvant (A) | 2018-08-08 | 2018-09-20 | Cyclophosphamide + Docetaxel | null | Y | 10485119 | DOCETAXEL + TRASTUZUMAB |
| 10006973 | 10004817 | 1.55 | 69.8 | Palliative (P) | 2016-01-23 | 2016-01-28 | DABRAFENIB + TRAMETINIB | 02 | null | 10485119 | DOCETAXEL + TRASTUZUMAB |
| 10006974 | 10008555 | 1.67 | 56 | Neo-adjuvant (N) | 2014-12-22 | 2015-11-07 | Cytarabine intrathecal | 02 | N | 10485126 | PILOT TRIAL |
| 10006975 | 10004818 | 1.7 | null | null | 2015-11-27 | 2015-12-23 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 10485352 | CAPECITABINE + CARBOPLATIN |
| 10006976 | 10004819 | 1.57 | 60 | Palliative (P) | 2016-11-01 | 2016-11-16 | PERTUZUMAB + TRASTUZUMAB | 02 | N | 10485352 | NAB-PACLITAXEL |
| 10006977 | 10004820 | null | 104.5 | Palliative (P) | null | 2019-05-08 | BORTEZOMIB + THALIDOMIDE | 01 | N | 10485395 | BENDAMUSTINE + OBINUTUZUMAB |
| 10006978 | 10004820 | 1.77 | 97 | Palliative (P) | 2014-09-26 | 2014-09-29 | CYCLOPHOSPHAMIDE + MESNA | N | N | 10485395 | AFATINIB |
| 10006979 | 10008556 | 1.77 | 70 | Palliative (P) | 2018-04-15 | 2018-04-20 | ECX | N | N | 10485667 | CETUXIMAB |
| 10006980 | 10004823 | 1.74 | null | Palliative (P) | 2018-05-15 | 2018-06-14 | Gemcitabine + Capecitabine | N | N | 10485727 | PACLITAXEL + RAMUCIRUMAB |
| 10006981 | 10004824 | 1.73 | 75.8 | Palliative (P) | 2018-09-26 | 2018-09-28 | Pazopanib | N | N | 10485867 | BORTEZOMIB |
| 10006982 | 10004825 | 1.7 | 90.6 | Palliative (P) | 2017-02-04 | 2017-02-07 | EOX | N | N | 10486032 | CARMUSTINE + THIOTEPA |
| 10006983 | 10004826 | 1.78 | 81 | Palliative (P) | 2016-12-30 | 2016-12-30 | AFATINIB | N | N | 10486037 | CAPECITABINE + CISPLATIN + RT |
| 10006984 | 10004827 | 1.5 | 76 | Palliative (P) | 2016-03-31 | 2016-05-27 | FEC | 02 | N | 10486052 | CVD |
| 10006985 | 10004829 | 1.52 | 81.8 | Palliative (P) | 2017-12-19 | 2017-12-21 | FEC 100 + DOCETAXEL | 02 | Y | 10486090 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 10006986 | 10004829 | 1.8 | 72 | Adjuvant (A) | 2017-12-22 | 2018-01-09 | Methotrexate intrathecal | N | N | 10486090 | FLUOROURACIL + MITOMYCIN + RT |
| 10006987 | 10004830 | 1.8 | 72.7 | Palliative (P) | null | 2014-08-18 | Topotecan (oral) | N | N | 10486160 | ECX |
| 10006988 | 10004831 | 1.5 | null | Palliative (P) | 2018-10-21 | 2018-10-22 | DABRAFENIB + TRAMETINIB | N | N | 10486306 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 10006989 | 10004832 | null | 77 | Palliative (P) | 2018-03-01 | 2018-03-14 | DA-EPOCH-R | N | N | 10486417 | CARBOPLATIN + DOCETAXEL |
| 10006990 | 10004834 | 1.69 | 83.35 | Adjuvant (A) | 2017-07-29 | 2017-07-29 | CYTARABINE | N | N | 10486537 | PERTUZUMAB + TRASTUZUMAB |
| 10006991 | 10004835 | 1.83 | 91 | Palliative (P) | 2016-05-22 | 2016-05-23 | RPACE-BOM | N | N | 10486606 | MELPHALAN |
| 10006992 | 10004837 | 1.7 | null | Palliative (P) | 2019-04-01 | 2019-04-08 | Cytarabine intrathecal | null | N | 10486704 | BUSULPHAN |
| 10006993 | 10004837 | 1.7 | 67.3 | Palliative (P) | 2017-06-03 | 2017-06-03 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 2 | N | 10486704 | EPIRUBICIN |
| 10006994 | 10004838 | 1.73 | 65.8 | Curative (C) | 2019-01-05 | 2019-01-05 | Vinorelbine IV | N | N | 10486800 | IRINOTECAN |
| 10006995 | 10004839 | 1.71 | 74 | Palliative (P) | 2016-06-03 | 2017-03-02 | Erlotinib | N | null | 10486800 | GEMCITABINE + PACLITAXEL |
| 10006996 | 10004840 | 1.7 | 64.1 | Adjuvant (A) | 2015-10-29 | 2015-11-29 | PCV | 2 | N | 10486870 | OXALIPLATIN + MDG + PANITUMUMAB |
| 10006997 | 10007439 | 1.76 | 57 | Palliative (P) | 2014-10-20 | 2014-10-21 | Cladribine (subcut) 5 days | 2 | N | 10486881 | NIVOLUMAB |
| 10006998 | 10004842 | 1.78 | 77.9 | Adjuvant (A) | 2015-09-05 | 2015-09-06 | Bortezomib + CYCLOPHOSPHAMIDE | 2 | N | 10487162 | IMATINIB |
| 10006999 | 10004843 | 1.7 | 95 | Adjuvant (A) | 2017-09-22 | 2017-10-21 | Bendamustine + Obinutuzumab | 02 | N | 10487248 | ENZALUTAMIDE |
| 10007000 | 10004845 | 1.79 | 61 | Adjuvant (A) | 2015-12-15 | 2015-12-22 | GEMCITABINE + NAB PACLITAXEL | null | null | 10487275 | POMALIDOMIDE |
| 10007001 | 10007440 | 1.5 | 69.5 | Not known (9) | 2016-07-30 | 2016-08-27 | Cyclophosphamide High Dose | 2 | N | 10487339 | FLAIR TRIAL |
| 10007002 | 10004847 | 1.72 | 73 | Adjuvant (A) | 2018-12-05 | 2019-05-15 | Cladribine (subcut) 5 days | 2 | N | 10487348 | MITOMYCIN INTRAVESICULAR |
| 10007003 | 10004848 | 1.73 | 79 | Neo-adjuvant (N) | 2016-11-04 | 2016-11-11 | Bexarotene | 02 | N | 10487421 | DOCETAXEL + NINTEDANIB |
| 10007004 | 10004850 | 1.71 | 63 | Palliative (P) | 2017-04-17 | 2017-04-23 | EC | 2 | N | 10487433 | DABRAFENIB + TRAMETINIB |
| 10007005 | 10007442 | 1.68 | 80 | Palliative (P) | 2018-07-12 | 2018-08-10 | OXALIPLATIN + MDG + PANITUMUMAB | N | N | 10487540 | CAPECITABINE + GEMCITABINE |
| 10007006 | 10007442 | null | 93.6 | Adjuvant (A) | 2017-03-09 | 2017-04-14 | R IVAC | 02 | N | 10487540 | FCR |
| 10007007 | 10007442 | 1.55 | 74.1 | Palliative (P) | null | 2018-02-12 | QUASAR 2 TRIAL | N | N | 10487540 | ENRICH TRIAL |
| 10007008 | 10004851 | 1.59 | 75.8 | Not known (9) | 2015-04-19 | 2015-05-10 | Methotrexate intrathecal | 2 | N | 10487687 | METHOTREXATE INTRATHECAL |
| 10007009 | 10004852 | 1.7 | 95 | Palliative (P) | null | 2018-05-04 | Busulfan Oral | N | N | 10487753 | BENDAMUSTINE + OBINUTUZUMAB |
| 10007010 | 10004854 | 1.67 | 58 | Adjuvant (A) | 2016-05-17 | 2016-05-20 | Cyclophosphamide High Dose | N | N | 10487949 | BENDAMUSTINE |